Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations
about
Patient Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Development and Screening In Catecholaminergic Polymorphic Ventricular TachycardiaTranslation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision MedicineAdeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia.SK4 K+ channels are therapeutic targets for the treatment of cardiac arrhythmiasCalcium signaling in human stem cell-derived cardiomyocytes: Evidence from normal subjects and CPVT afflicted patientsInduced pluripotent stem cells: at the heart of cardiovascular precision medicine.Human Induced Pluripotent Stem Cells as a Platform for Personalized and Precision Cardiovascular Medicine.Perspectives and Challenges of Pluripotent Stem Cells in Cardiac Arrhythmia Research.Calcium Signaling and Cardiac Arrhythmias.The N-Terminal Region of the Ryanodine Receptor Affects Channel Activation.Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.An optogenetic arrhythmia model to study catecholaminergic polymorphic ventricular tachycardia mutations.Investigating the cardiac pathology of SCO2-mediated hypertrophic cardiomyopathy using patients induced pluripotent stem cell-derived cardiomyocytes.Detection of genetic cardiac diseases by Ca2+ transient profiles using machine learning methods.
P2860
Q28067569-E4D4D109-4074-407F-812E-1050B3652795Q28076397-503CEA5F-1E2B-42DC-B72E-8C1A863BDB2BQ37465870-CE7DA006-CD20-4A77-A43F-503D537362E6Q37734009-82EB6551-51F7-4142-AB46-26462B30D676Q38685507-AF67E6DA-3DF1-4FD8-8BB8-6CF3785C9E89Q38786687-EF630E47-6425-4912-AB73-4FAC39BCA64AQ38874111-E6261841-CEA2-455F-A4CF-325941291D58Q39144910-2C430B01-68C2-4E65-926A-E1F3BC11DF52Q39360546-DD5F53E3-6B93-4F1E-92E5-503A3A3B96F8Q40995486-98E272C2-D230-4F10-9D6E-BD7AF7A8AEE5Q41664792-EF646126-A108-480B-986F-D9CD49B40869Q47298913-974C7295-3905-4C47-96BB-449EF1C4BE8BQ48199735-5771F38D-2537-4BA4-A92E-D3B6F9396593Q55361234-54A72FD9-9EF3-4704-A46C-5F3B048D79A7
P2860
Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Functional abnormalities in iP ...... ine or calsequestrin mutations
@ast
Functional abnormalities in iP ...... ine or calsequestrin mutations
@en
type
label
Functional abnormalities in iP ...... ine or calsequestrin mutations
@ast
Functional abnormalities in iP ...... ine or calsequestrin mutations
@en
prefLabel
Functional abnormalities in iP ...... ine or calsequestrin mutations
@ast
Functional abnormalities in iP ...... ine or calsequestrin mutations
@en
P2093
P2860
P356
P1476
Functional abnormalities in iP ...... ine or calsequestrin mutations
@en
P2093
Atara Novak
Avraham Lorber
Irina Reiter
Joseph Itskovitz-Eldor
Lili Barad
Liron Eldor
Michael Arad
Michael Eldar
Mihaela Gherghiceanu
P2860
P304
P356
10.1111/JCMM.12581
P577
2015-07-08T00:00:00Z